EFG International AG Invests $2.55 Million in Stryker Corporation $SYK

EFG International AG acquired a new stake in Stryker Corporation (NYSE:SYK) during the second quarter, Holdings Channel reports. The institutional investor acquired 8,097 shares of the medical technology company’s stock, valued at approximately $2,550,000.

A number of other institutional investors have also made changes to their positions in the business. Gables Capital Management Inc. bought a new position in Stryker in the second quarter valued at $25,000. Kilter Group LLC bought a new stake in Stryker during the 2nd quarter worth about $25,000. Godfrey Financial Associates Inc. acquired a new position in shares of Stryker during the 4th quarter worth about $26,000. Sankala Group LLC acquired a new position in shares of Stryker during the 4th quarter worth about $26,000. Finally, Compass Financial Management LLC bought a new position in shares of Stryker in the 2nd quarter valued at about $27,000. Institutional investors own 77.09% of the company’s stock.

Wall Street Analyst Weigh In

A number of analysts recently issued reports on the company. Needham & Company LLC lowered their target price on Stryker from $454.00 to $418.00 and set a “buy” rating on the stock in a research report on Friday, May 1st. BMO Capital Markets began coverage on Stryker in a research note on Wednesday, July 8th. They issued an “outperform” rating and a $369.00 price target for the company. JPMorgan Chase & Co. decreased their price target on Stryker from $400.00 to $350.00 and set an “overweight” rating for the company in a research note on Friday, July 31st. Weiss Ratings reiterated a “hold (c)” rating on shares of Stryker in a research note on Friday, July 31st. Finally, Sanford C. Bernstein set a $410.00 price objective on Stryker in a report on Friday, May 1st. One analyst has rated the stock with a Strong Buy rating, seventeen have assigned a Buy rating and six have assigned a Hold rating to the stock. According to data from MarketBeat.com, Stryker currently has a consensus rating of “Moderate Buy” and an average target price of $386.28.

Insider Activity at Stryker

In other news, insider Dylan Bram Crotty sold 441 shares of the business’s stock in a transaction that occurred on Friday, August 21st. The stock was sold at an average price of $328.61, for a total transaction of $144,917.01. Following the completion of the sale, the insider owned 6,102 shares in the company, valued at $2,005,178.22. The trade was a 6.74% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, Director Ronda E. Stryker sold 300,000 shares of the company’s stock in a transaction that occurred on Tuesday, August 18th. The shares were sold at an average price of $335.90, for a total value of $100,770,000.00. Following the completion of the transaction, the director directly owned 2,301,375 shares in the company, valued at $773,031,862.50. The trade was a 11.53% decrease in their position. The SEC filing for this sale provides additional information. In the last 90 days, insiders have sold 351,267 shares of company stock worth $118,197,701. Insiders own 4.60% of the company’s stock.

Stryker Price Performance

Shares of NYSE SYK opened at $330.08 on Thursday. The company has a quick ratio of 1.33, a current ratio of 2.16 and a debt-to-equity ratio of 0.59. The business’s 50 day moving average price is $328.37 and its two-hundred day moving average price is $331.72. The company has a market cap of $126.61 billion, a PE ratio of 34.21, a price-to-earnings-growth ratio of 2.11 and a beta of 0.76. Stryker Corporation has a twelve month low of $281.00 and a twelve month high of $396.86.

Stryker (NYSE:SYK) last released its quarterly earnings data on Thursday, July 30th. The medical technology company reported $3.69 EPS for the quarter, topping analysts’ consensus estimates of $3.49 by $0.20. Stryker had a net margin of 14.43% and a return on equity of 23.63%. The firm had revenue of $6.59 billion during the quarter, compared to analysts’ expectations of $6.58 billion. During the same period in the previous year, the business posted $3.13 earnings per share. The company’s revenue for the quarter was up 9.4% compared to the same quarter last year. Stryker has set its FY 2026 guidance at 14.950-15.100 EPS. On average, analysts predict that Stryker Corporation will post 15.02 EPS for the current year.

Stryker Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, October 30th. Investors of record on Wednesday, September 30th will be issued a dividend of $0.88 per share. The ex-dividend date of this dividend is Wednesday, September 30th. This represents a $3.52 annualized dividend and a dividend yield of 1.1%. Stryker’s payout ratio is presently 36.48%.

Stryker Company Profile

Stryker Corporation is a global medical technology company that designs, manufactures and markets a broad range of products and services for use in hospitals, surgeons’ offices and other healthcare facilities. Its primary business activities span orthopedics (including joint replacement implants, trauma and extremities products), surgical equipment and operating room technologies (such as visualization, navigation and powered instruments), neurotechnology and spine solutions, and patient-handling and emergency medical equipment.